Novartis Completes Acquisition of 98 Percent of Eon Labs, Substantially Strengthening the Leading Position of its Sandoz Generics Unit
21 juil. 2005 08h21 HE
|
Novartis
BASEL, Switzerland, July 21, 2005 (PRIMEZONE) --Novartis announced today that it has completed the acquisition of approximately 98 percent of U.S.-based generic pharmaceutical company Eon Labs, Inc....
Novartis Completes Tender Offer For Eon Labs, Inc. and Purchase of Majority Stake
21 juil. 2005 05h16 HE
|
Novartis
BASEL, Switzerland, July 21, 2005 (PRIMEZONE) -- Novartis announced today that Zodnas Acquisition Corp., an indirect wholly owned subsidiary of Novartis AG, has successfully completed its tender...
Novartis Receives U.S. Regulatory Approval for Completion of Eon Labs Acquisition
19 juil. 2005 11h30 HE
|
Novartis
BASEL, Switzerland, July 19, 2005 (PRIMEZONE) -- Novartis announced today that the U.S. Federal Trade Commission has accepted a Consent Decree for public comment and granted early termination of the...
Novartis to Acquire North American OTC Brand Portfolio from Bristol-Myers Squibb
14 juil. 2005 16h00 HE
|
Novartis
BASEL, Switzerland, July 14, 2005 (PRIMEZONE) -- Novartis announced today that it has agreed to acquire the rights to a portfolio of over-the-counter (OTC) products - led by the pain medicine...
Novartis Reports Strong Results in the First Six Months of 2005
14 juil. 2005 01h15 HE
|
Novartis
BASEL, Switzerland, July 14, 2005 (PRIMEZONE) -- Novartis AG (NYSE:NVS):
-- Group first-half net sales rise 11% (+8% lc) thanks to dynamic
performances by all divisions
-- Strong expansion...
Novartis Submits Applications in U.S. and Europe for Femara as Adjuvant Treatment for Postmenopausal Women With Early Breast Cancer
11 juil. 2005 01h30 HE
|
Novartis
Pre-Planned Subset Analyses Show Femara Reduces Risk of Cancer
Returning by Up to 30% in Node-Positive and Chemotherapy-Treated
Patients
BASEL, Switzerland, July 11, 2005 (PRIMEZONE) --...
Novartis Reaches Agreement to Settle US Lawsuit Related to Eon Labs Acquisition
08 juil. 2005 14h37 HE
|
Novartis
BASEL, Switzerland, July 8, 2005 (PRIMEZONE) -- Novartis announced today that it and the other defendants in a lawsuit related to the acquisition of Eon Labs, Inc. (Nasdaq:ELAB) have reached an...
Novartis Extends Tender Offer for Eon Labs, Inc. Through July 13, 2005
05 juil. 2005 07h13 HE
|
Novartis
BASEL, Switzerland, July 5, 2005 (PRIMEZONE) -- Novartis announced today that Zodnas Acquisition Corp., an indirect wholly owned subsidiary of Novartis, is extending its cash tender offer to acquire...
Xolair (omalizumab) Add-On Therapy Significantly Reduces Attacks in Patients With Severe Allergic Asthma
01 juil. 2005 01h30 HE
|
Novartis
BASEL, Switzerland and MUNICH, Germany, July 1, 2005 (PRIMEZONE) -- Data from seven clinical studies presented at the World Allergy Congress in Germany demonstrate that in patients with severe...
Novartis Licenses Rights to Develop and Commercialize New Respiratory Syncytial Virus (RSV) Treatment
30 juin 2005 01h31 HE
|
Novartis
BASEL, Switzerland, June 30, 2005 (PRIMEZONE) -- Novartis (NYSE:NVS)announced today that it has signed an exclusive global license agreement with Arrow Therapeutics, Ltd. for A-60444 a first-in-class...